In addition, we investigated the possible mechanism of action of JAKi and MTX treatment on the fibrotic state of RA-ILD patients by investigating their effects on IL-6-induced EMT in alveolar epithelial cells in vitro. The gene discussed is IL6; the disease is rheumatoid arthritis.